The global loop-mediated isothermal amplification (LAMP) market is estimated to garner a revenue of ~USD 180 million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 110 billion in the year 2022. The growth of the market can be attributed to the increasing number of chronic diseases among the population around the world. Further, the growing prevalence of illnesses such as diabetes, cardiovascular and respiratory diseases, cancer, and others, owing to the consumption of unhealthy foods, and rising stress levels among people are also expected to increase the utilization rate of loop-mediated isothermal amplification (LAMP) in the assessment period. It was found during research that more than 19.8% of India’s population suffers from at least one chronic illness, and nearly 10.1% of persons have multiple chronic illnesses.
Get more information on this report:Apart from the aforementioned factors, the market growth is also attributed to the rising need for the detection of pathogens in patient samples owing to the increasing cases of infection across the globe. Tuberculosis, hepatitis, and influenza are some of the infectious diseases that are responsible for taking millions of lives every year. Thus, the advantages of loop-mediated isothermal amplification, including disease-specific testing options, have made it a preferred option in various clinical and industrial settings. It was noted that at least 2 million Americans contract an infection that is unable to be treated each year, and at least 23,000 of them pass away.
Base Year |
2022 |
Forecast Year |
2023-2033 |
CAGR |
~ 6% |
Base Year Market Size (2022) |
~ USD 110 Million |
Forecast Year Market Size (2033) |
~ USD 180 Million |
Regional Scope |
|
Increasing Investment in Research and Development – It was noticed that global research and development spending has more than tripled in real terms since 2000, rising from USD 677 billion to USD 2.2 trillion in 2019. The market is estimated to gain a significant boost over the forecast period owing to increasing investment in the R&D sector of the pharmaceutical industry. Along with that, the high expenditure made in the field of the healthcare sector is supporting laboratory tests to provide quick and more accurate results, which are anticipated to bring growth opportunities for the market in the upcoming years.
Rising Expenditure in the Healthcare Sector – With the high prevalence of diseases around the world, people everywhere are propelled to spend more money on diagnostics and treatment processes that are forecasted to increase the utilization rate of loop-mediated isothermal amplification. Moreover, the recent government investment in the healthcare sector is also anticipated to bring new chances for market expansion in the future. As per the World Health Organization, global health spending has increased overall during the previous 20 years, doubling in real terms, reaching USD 8.5 trillion in 2019 and 9.8% of GDP up, from 8.5 percent in 2000.
Growing Prevalence of Pandemic Diseases – On October 19, 2022, the WHO received reports of 623,000,396 confirmed cases of COVID-19 worldwide, including 6,550,033 fatalities.
Rising Malaria Infection - Globally, there were presumably 241 million cases of malaria in 2020, and 627 000 deaths from malaria were estimated in 2020.
High Investment in Technological Advancement –Before the pandemic, investments in innovation were at an all-time high. In 2019, R&D grew at an unprecedented rate of 8.5 percent in the United States. Moreover, Switzerland, Sweden, the U.S., and the U.K. are still at the top of the list for innovation and have been for the previous three years.
The global loop-mediated isothermal amplification (LAMP) market is segmented and analyzed for demand and supply by end-user in hospital laboratories, research and academic institutes, and diagnostic centers. Out of these, the hospital laboratories segment is estimated to gain the largest market share by the end of 2033 owing to the high spending by patients to receive test results from reputable laboratories and their association with blood banks, hospitals, and specialist diagnostic centers. It is believed that by 2024, the medical and diagnostic laboratories of hospitals in the United States are estimated to generate around USD 54 billion in revenue. In addition to this, the release of precise and cutting-edge devices, including companion diagnostics, biochips, microarrays, and other technological advancements in the laboratories segment, is estimated to drive the segment growth over the forecast period.
The global loop-mediated isothermal amplification (LAMP) market is also segmented and analyzed for demand and supply by application for diagnostic and research purposes. Out of these two segments, the diagnostics segment is expected to garner the highest segment share owing to the rising need for diagnosing diseases among the population. The sudden shift towards unhealthy lifestyles and the consumption of deleterious food items is generating illnesses and infections that need to be diagnosed and treated. As a result, the demand for loop-mediated isothermal amplification is forecast to increase in the upcoming few years.
Our in-depth analysis of the global loop-mediated isothermal amplification (LAMP) market includes the following segments:
By Technology |
|
By Application |
|
By End User |
|
The North American loop-mediated isothermal amplification (LAMP) market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the increasing frequency of people being diagnosed with chronic diseases generating the need for loop-mediated isothermal amplification as a point-of-care genetic testing for treatment purposes. Recent statistics revealed that in the USA, 4 in 10 adults have two or more chronic diseases, and 6 in 10 have at least one chronic disease. Further, the high prevalence of infectious diseases among Americans is also expected to bring lucrative opportunities for using loop-mediated isothermal amplification for diagnosing and market expansion in the forecast period. Apart from these, the other contributing factor to the market’s growth is the presence of a strong healthcare network along with the major key players in the region. Moreover, the large pool of patients and their high expenditure on the healthcare sector, along with favorable policies, are also anticipated to contribute to the market’s growth in the region. In addition, the region's expanding investment to develop technologically advanced healthcare products and in the research and development (R&D) sector is also anticipated to boost market growth during the forecast period.
Thermo Fisher Scientific
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: The increasing prevalence of chronic diseases and infection-related illnesses are the main factors driving the growth of the loop-mediated isothermal amplification (LAMP) market.
Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.
Ans: The rising complexity and high cost of LAMP are estimated to be the growth-hindering factors for market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Nippon Gene Co., Ltd., Omega Bio-tek, Inc., LGC Limited, Excellgen.com, Meridian Bioscience, Inc., HiberGene Diagnostics, Jena Bioscience GmbH, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by technology, application, end-user, and by region.
Ans: The hospital laboratories segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)